相似文献
1
Sensitivity, Specificity, PPV, and NPV for Predictive Biomarkers.
J Natl Cancer Inst. 2015 Jun 24;107(8). doi: 10.1093/jnci/djv153. Print 2015 Aug.
2
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
Lancet Oncol. 2015 Oct;16(13):1324-34. doi: 10.1016/S1470-2045(15)00188-6. Epub 2015 Sep 3.
3
The Fundamental Difficulty With Evaluating the Accuracy of Biomarkers for Guiding Treatment.
J Natl Cancer Inst. 2015 Jun 24;107(8). doi: 10.1093/jnci/djv157. Print 2015 Aug.
4
Personalized oncology: recent advances and future challenges.
Metabolism. 2013 Jan;62 Suppl 1:S11-4. doi: 10.1016/j.metabol.2012.08.016. Epub 2012 Sep 19.
5
PD-L1 Testing in Cancer: Challenges in Companion Diagnostic Development.
JAMA Oncol. 2016 Jan;2(1):15-6. doi: 10.1001/jamaoncol.2015.4685.
6
Estimating sensitivity and specificity from positive predictive value, negative predictive value and prevalence: application to surveillance systems for hospital-acquired infections.
J Hosp Infect. 2008 Jun;69(2):164-8. doi: 10.1016/j.jhin.2008.02.021. Epub 2008 Apr 29.
7
Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Eur J Radiol. 2011 Nov;80(2):462-70. doi: 10.1016/j.ejrad.2010.07.017. Epub 2010 Aug 13.
8
Accuracy of breast magnetic resonance imaging in predicting pathologic response in patients treated with neoadjuvant chemotherapy.
Clin Breast Cancer. 2011 Oct;11(5):312-9. doi: 10.1016/j.clbc.2011.06.007. Epub 2011 Aug 10.
9
Sensitivity, specificity, positive predictive value, and negative predictive value of the dipyridamole sestamibi stress test comparing arterial to vein conduits.
Chest. 2004 Oct;126(4):1040-1. doi: 10.1378/chest.126.4.1040.
10
Detection of Chromosomal Abnormalities with Different In Situ Hybridisation Techniques--the Usefulness in the Qualification of Cancer Patients for Molecularly-Targeted Therapies.
Adv Clin Exp Med. 2015 Jul-Aug;24(4):715-23. doi: 10.17219/acem/28825.
引用本文的文献
1
A Reproducibility Crisis for Clinical Metabolomics Studies.
Trends Analyt Chem. 2024 Nov;180. doi: 10.1016/j.trac.2024.117918. Epub 2024 Aug 19.
2
Advances on Electrochemiluminescent Biosensors for TB Biomarkers.
ACS Sens. 2025 Apr 25;10(4):2409-2430. doi: 10.1021/acssensors.4c03517. Epub 2025 Apr 9.
3
Real-world clinical validation of the Qatar pre-diabetes risk score: a cross-sectional study.
BMJ Public Health. 2024 Jun 17;2(1):e000957. doi: 10.1136/bmjph-2024-000957. eCollection 2024 Jun.
4
Intestinal Biomarkers and Their Importance in Canine Enteropathies.
Vet Med Int. 2024 Nov 13;2024:7409482. doi: 10.1155/vmi/7409482. eCollection 2024.
5
Clinical utility of bedside Contrast-Enhanced Ultrasound (CEUS) in the diagnosis of pneumonia in elderly patients: Comparison with clinical, -radiological and ultrasound diagnosis.
Multidiscip Respir Med. 2024 Oct 1;19(1):967. doi: 10.5826/mrm.2024.967.
6
A computational clinical decision-supporting system to suggest effective anti-epileptic drugs for pediatric epilepsy patients based on deep learning models using patient's medical history.
BMC Med Inform Decis Mak. 2024 May 31;24(1):149. doi: 10.1186/s12911-024-02552-w.
7
Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era.
Hematol Transfus Cell Ther. 2024 Dec;46 Suppl 6(Suppl 6):S3-S12. doi: 10.1016/j.htct.2023.07.008. Epub 2023 Oct 12.
8
Safe and valid? A systematic review of the psychometric properties of culturally adapted depression scales for use among Indigenous populations.
Glob Ment Health (Camb). 2023 Sep 14;10:e60. doi: 10.1017/gmh.2023.52. eCollection 2023.
9
Diagnostic Performance of Anti-Topoisomerase-I, Anti-Th/To Antibody and Anti-Fibrillarin Using Immunoblot Method in Systemic Sclerosis Related Interstitial Lung Disease Patients.
Open Access Rheumatol. 2023 Apr 28;15:43-49. doi: 10.2147/OARRR.S403403. eCollection 2023.
10
Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review.
Int J Mol Sci. 2023 Feb 3;24(3):2969. doi: 10.3390/ijms24032969.
本文引用的文献
1
Analyzing longitudinal data to characterize the accuracy of markers used to select treatment.
Stat Med. 2014 Jul 30;33(17):2881-96. doi: 10.1002/sim.6138. Epub 2014 Mar 13.
2
Assessing treatment-selection markers using a potential outcomes framework.
Biometrics. 2012 Sep;68(3):687-96. doi: 10.1111/j.1541-0420.2011.01722.x. Epub 2012 Feb 2.
3
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.
J Clin Oncol. 2008 Apr 1;26(10):1626-34. doi: 10.1200/JCO.2007.14.7116. Epub 2008 Mar 3.
Zotero 插件